Why Did My Peptides Stop Working? Tolerance, Storage, and Dosing Mistakes

Written by NorthPeptide Research Team

It Was Working. Now It’s Not.

You’ve been using a peptide for weeks — maybe months. At first, the results were obvious. You felt it working. The numbers moved in the right direction. Then, gradually or suddenly, things stalled. The effects faded. The results plateaued. Nothing changed in your routine, but the peptide just… stopped.

This is one of the most common frustrations in peptide research. And the good news is: there’s almost always a reason. Once you identify it, you can fix it.

This article covers the five most common reasons peptides stop working — and what to do about each one.

Reason 1: Tolerance (It’s Real — But It Depends on the Peptide)

Tolerance — when your body adapts to a substance and responds less to it over time — is a real phenomenon. But it doesn’t affect all peptides equally. Understanding which peptides develop tolerance and which don’t is critical.

GLP-1 Agonists (Semaglutide, Tirzepatide, Retatrutide)

These weight loss peptides do show a specific type of tolerance. Research has documented rapid tachyphylaxis — a fast reduction in response — to the gastric emptying effects of GLP-1 drugs. Your stomach stops slowing down as much, which means that “full after three bites” feeling fades (PMC3292331).

However, the overall weight loss effect doesn’t disappear — it just plateaus. With semaglutide, the weight loss plateau typically occurs around 60-68 weeks. The body reaches a new equilibrium where energy intake and expenditure balance out at the lower weight. This isn’t the drug “stopping” — it’s the body reaching a new set point (PMID: 38644683).

The adaptive thermogenesis piece matters too. As you lose weight, your body burns fewer calories at rest. GLP-1 drugs can reduce lean muscle and lower resting energy expenditure, creating a metabolic slowdown that contributes to the plateau (PMC11940170).

Growth Hormone Secretagogues (GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Sermorelin)

These peptides are more prone to tolerance. Research on growth hormone secretagogues has shown that repeated injections can desensitize the GH release response. With hexarelin specifically, continuous exposure has been shown to alter components of the growth axis (PMC5632578).

This is why cycling is commonly discussed with GH secretagogues. More on that below.

BPC-157

Good news here. BPC-157 does not appear to develop significant tolerance based on available research. Studies have shown it to be well tolerated at high doses without evidence of tachyphylaxis. In fact, research has found that BPC-157 may actually counteract tolerance development to other compounds like diazepam (PMC11053547). However, it’s worth noting that the BPC-157 research literature has limitations — the majority of published studies come from a single research center, and there’s limited data on long-term, repeated use (PMC12446177).

TB-500

TB-500 (thymosin beta-4 fragment) is primarily used for recovery and tissue repair. Like BPC-157, it doesn’t show strong tolerance patterns in the available research. The mechanism of action — promoting cell migration and blood vessel formation — works on structural pathways that don’t desensitize the way receptor-mediated pathways can.

Reason 2: Storage Mistakes That Destroy Your Peptides

This is probably the most common reason peptides “stop working” — and the one people think about least. Peptides are fragile molecules. Improper storage degrades them, reducing their potency or destroying them entirely. And you can’t see it happen.

Heat

Heat is the enemy. Peptides break down faster at higher temperatures. A comparative study of peptide storage conditions found significant degradation at room temperature compared to -20°C and -80°C storage (PMC3630641).

Practical translation: if your peptide vial sat in a hot mailbox, on a sunny windowsill, or next to a heating vent for even a few hours, it may have lost potency. Lyophilized (powdered) peptides handle temperature better than reconstituted ones — but neither should see heat.

Light

UV light damages certain amino acid residues, especially tryptophan and tyrosine. Store peptides in their original packaging or wrap vials in foil. Never leave them exposed to sunlight or bright fluorescent lighting.

Freeze-Thaw Cycles

This one catches a lot of people. Taking a reconstituted peptide out of the freezer, letting it thaw to use, then putting it back — repeated freeze-thaw cycles physically damage the peptide structure. Research has specifically documented that peptides containing cysteine, methionine, or tryptophan residues are especially vulnerable to oxidation accelerated by freeze-thaw cycles (PMC9610364).

Rule of thumb: once you reconstitute a peptide, keep it in the refrigerator (2-8°C) — don’t freeze and thaw it repeatedly.

Proper Storage Summary

Peptide State	Best Storage	How Long It Lasts	Key Rule
Lyophilized (powder)	-20°C (freezer)	Months to years	Keep dry, away from light
Reconstituted (mixed)	2-8°C (fridge)	4-6 weeks	Never freeze-thaw repeatedly
In transit (shipping)	Cool packs if possible	A few days is fine	Unpack and refrigerate ASAP

Reason 3: Dosing Mistakes

Dosing errors are surprisingly common, especially with peptides that require reconstitution and calculation. Here are the most frequent mistakes:

Inconsistent Timing

Many peptides work best when taken at consistent times. GH secretagogues like sermorelin are most effective on an empty stomach, typically before bed. Taking them at random times — or after eating — can significantly reduce their effect.

Wrong Calculation After Reconstitution

When you mix a peptide with bacteriostatic water, the concentration depends on how much water you add. Get the math wrong, and every dose after that is either too high or too low.

Example: You have a 5 mg vial. You add 1 mL of bacteriostatic water. That gives you 5 mg/mL. Each 0.1 mL (10 units on an insulin syringe) = 0.5 mg. But if you accidentally added 2 mL of water, each 0.1 mL is only 0.25 mg — half the dose you think you’re taking.

Always write down exactly how much water you added. Then do the math before every dose.

Not Adjusting for Body Weight Changes

If you’ve lost or gained significant weight since you started, your effective dose may have shifted. A dose that worked at 220 lbs may be insufficient — or excessive — at 180 lbs. This is especially relevant for weight-dependent compounds.

Reason 4: Your Bacteriostatic Water Has Gone Bad

Bacteriostatic water contains 0.9% benzyl alcohol as a preservative. This keeps bacteria from growing in the vial. But it doesn’t last forever.

Once you puncture the vial, you have 28 days of use — per USP guidelines. After that, sterility can’t be guaranteed. If you’re using bacteriostatic water that’s been open for months, you might be introducing bacteria into your peptide solution every time you draw from it.

Contaminated bacteriostatic water can:

• Introduce bacteria that degrade the peptide
• Cause cloudiness or particulate matter in the solution
• Reduce the effective potency of the reconstituted peptide
• Create potential safety issues

Simple rule: Write the date on your BAC water vial when you first open it. After 28 days, use a new one. They’re inexpensive — this is not the place to save money.

Reason 5: Reconstitution Errors

Beyond the math, the physical process of mixing peptides matters. Common reconstitution mistakes include:

Shaking the Vial

Never shake a peptide vial. Vigorous shaking can denature — basically unfold and damage — the peptide structure. This creates aggregation, where the peptide molecules clump together and lose their biological activity. Research on peptide stability specifically identifies aggregation as a major factor affecting therapeutic peptide function (PMC5665799).

Instead, gently swirl the vial. Or let the water run down the side of the vial and allow the peptide to dissolve naturally. It might take a few minutes. That’s fine.

Squirting Water Directly onto the Powder

When adding bacteriostatic water, aim the stream at the glass wall of the vial — not directly onto the peptide cake. Direct pressure can break up the peptide powder in a way that leads to uneven mixing or structural damage.

Using the Wrong Diluent

Most peptides should be reconstituted with bacteriostatic water. But some — like certain growth hormone fragments — may work better with acetic acid water (0.6% acetic acid solution) because of their pH sensitivity. Using the wrong diluent can affect solubility and stability.

When to Cycle Off — And How

For peptides that do develop tolerance — especially growth hormone secretagogues — cycling is the standard approach. Here’s a practical framework:

GH Secretagogues (GHRP-2, GHRP-6, Hexarelin, Ipamorelin)

Research suggests that continuous exposure to GH secretagogues can desensitize the GH release response (PMID: 9846166). A common cycling approach is 5 days on, 2 days off — or 8 weeks on, 2-4 weeks off. This allows the receptors to resensitize.

Ipamorelin was specifically developed as a more selective GH secretagogue with a cleaner side effect profile than earlier GHRPs (PMID: 9849822). Even so, cycling is generally recommended.

GLP-1 Agonists (Semaglutide, Tirzepatide)

Cycling off GLP-1 drugs is more complicated. Research from the STEP 1 trial extension showed that participants regained about two-thirds of their weight loss within one year of stopping semaglutide (PMC9542252). This suggests that discontinuation — even temporary — can undo results.

If you’re experiencing a plateau on a GLP-1 compound, the issue is more likely metabolic adaptation than classical tolerance. Options include:

• Adding resistance training to preserve lean muscle mass
• Adjusting caloric intake
• Considering a switch to a multi-receptor agonist like retatrutide (triple agonist) that may overcome single-receptor plateaus

BPC-157 and TB-500

These repair-oriented peptides don’t typically require cycling. Most protocols run for a defined period (4-12 weeks) targeting a specific healing goal, then stop when the objective is met. Since they don’t develop significant tolerance, the reason to stop is completion, not receptor desensitization.

A Quick Troubleshooting Checklist

Before you assume your peptide has stopped working, run through this list:

• Check your storage. Has the vial been exposed to heat, light, or freeze-thaw cycles?
• Check your BAC water date. Is it more than 28 days since you opened it?
• Recalculate your dose. Did you add the right amount of water during reconstitution?
• Check your timing. Are you taking the peptide at the right time (e.g., fasting for GH secretagogues)?
• Consider your body weight. Has it changed significantly since you started?
• Consider the compound. Is this a peptide known for tolerance development?
• Consider the source. Did you buy from a vendor with verified third-party testing?

If you’ve checked all of these and everything looks right, the issue might simply be that you’ve reached a natural plateau — especially with weight loss peptides. That’s not failure. That’s your body reaching a new equilibrium.

Summary of Key Research References

Reference	Topic	PMC / PMID
Rapid tachyphylaxis of GLP-1 gastric emptying deceleration	GLP-1 tolerance mechanism	PMC3292331
Physiology of the weight-loss plateau (diet, GLP-1 RA, surgery)	Weight loss plateau mechanisms	PMID: 38644683
Weight reduction with GLP-1 agonists and discontinuation paths	Metabolic adaptation and plateaus	PMC11940170
Safety and efficacy of growth hormone secretagogues	GHS tolerance and cycling	PMC5632578
BPC-157 pleiotropic beneficial activity and neurotransmitter activity	BPC-157 tolerance profile	PMC11053547
Regeneration or risk: narrative review of BPC-157	BPC-157 research limitations	PMC12446177
Comparative study of peptide storage conditions	Temperature and degradation	PMC3630641
Strategies for improving peptide stability and delivery	Freeze-thaw and oxidation damage	PMC9610364
Factors affecting physical stability of peptide therapeutics	Aggregation and denaturation	PMC5665799
Weight regain after semaglutide withdrawal (STEP 1 extension)	Post-discontinuation weight regain	PMC9542252
Effects of repeated doses of hexarelin in rats	GH secretagogue desensitization	PMID: 9846166
Ipamorelin: the first selective growth hormone secretagogue	Ipamorelin selectivity profile	PMID: 9849822

For laboratory and research use only. Not for human consumption.